Categories: News

Technology-Driven Behavioral Health Company SonderMind Raises $150 Million to Expand Mission of Improving Clinical Outcomes

Leading Behavioral Health Provider Will Continue to Expand Access Beyond the Current Footprint of 73 Million Insured Lives

DENVER–(BUSINESS WIRE)–SonderMind Inc., a national leader in improving mental health clinical outcomes and making behavioral health more accessible to all Americans, today announced the successful completion of a $150 million Series C financing. The round was co-led by new investors Drive Capital and Premji Invest, with participation from General Catalyst, Partners Group, Smash Ventures, Kickstart Fund, and F-Prime Capital.

SonderMind therapy works, and the company is on a mission to make sure it can work for everyone. The company’s technology is built for a more personalized mental health journey, so individuals seeking mental health support can get better faster. This funding will accelerate the company’s expansion into all fifty states as it continues to build the highest-quality platform for clinical care in the nation. The new capital infusion will also further SonderMind’s commitment to providing affordable and accessible mental healthcare that is grounded in data-driven results.

“I co-founded SonderMind in large part because of my frustration in trying to identify the right therapist who could help with my unique needs, had availability, and accepted my insurance. Getting high-quality behavioral health support should be simple and result in a great match,” said Mark Frank, co-founder and CEO of SonderMind. “With our partners in this funding round, SonderMind will bring our proven approach to behavioral health clinical outcomes to the entire country, while also bolstering the technology capabilities that have always been part of our core solution.”

Drive Capital’s Molly Bonakdarpour joins the SonderMind board in connection with the financing. Molly brings important experience working with high-growth health technology companies.

Bonakdarpour commented, “The essential need for behavioral health access is undeniable, and there is a growing field of companies looking to address the accessibility gap. SonderMind stood out to us as the market leader because of their clear approach to connecting individuals with therapists that meet their needs and take their insurance, all while producing clinically-verifiable outcomes for users. It is a win for all stakeholders: patients, therapists, and health plans. I’m so excited to work with the team to bring this approach national.”

Besides the aforementioned investors, additional institutional investors participating in the round were Founders Circle Capital, Zoma Foundation, and FCA Venture Partners. The Series C funding increases SonderMind’s total capital raised to date to $183 million.

About SonderMind

For mental health providers, SonderMind enables clinicians to thrive in a private-practice setting, while having the tools to deliver world-class care for their clients. SonderMind therapists enjoy being part of the premier community of providers who are empowered to focus on high-quality clinical outcomes, while the SonderMind solution takes care of the rest: matching clients who are a clinical fit, payments, telehealth, full technology suite, clinical assessments and a supportive team behind all of it.

For people seeking mental health support, SonderMind is centered around a commitment to provide individualized care that produces quality outcomes. Through innovative technology and a focus on the end-to-end journey, SonderMind is able to help millions of Americans not just find a therapist, but to find the right therapist for them.

For more information, please visit sondermind.com.

Partners Group is a leading global private markets firm, investing on behalf of its clients.

Contacts

Sloane & Company for SonderMind

Darren Brandt

dbrandt@sloanepr.com
917-903-6827

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

2 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

2 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

1 day ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

1 day ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

1 day ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

1 day ago